A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer

Novartis Investigative Site, Candiolo

Novartis Investigative Site, Córdoba

Novartis Investigative Site, Genova

Novartis Investigative Site, Milan

Novartis Investigative Site, Milan

Novartis Investigative Site, Monza

Duke University Medical Center Duke3, Durham

Novartis Investigative Site, Majadahonda

Hope A Woman's Cancer Center, Asheville

Novartis Investigative Site, Málaga

Novartis Investigative Site, Murcia

Florida Hospital Cancer Institute FL Hosp, Orlando

Novartis Investigative Site, Oviedo

University of South Alabama / Mitchell Cancer Institute Univ South Alabama, Mobile

Community Oncology Research Network, Chattanooga

The West Clinic SC, Memphis

Indiana University Health Goshen Center for Cancer IU Simon Cancer, Indianapolis

University of Iowa Hospitals & Clinics SC, Iowa City

Novartis Investigative Site, Pisa

Southeast Nebraska Oncology Cancer Center, Lincoln

Texas Oncology, P.A. Austin, Bedford

Texas Oncology, P.A. Tex Onc (3), Bedford

Texas Oncology, P.A. SC, Fort Worth

South Texas Oncology and Hematology, PA South Tex Onc, San Antonio

USC/Kenneth Norris Comprehensive Cancer Center USC 2, Los Angeles

Cedars Sinai Medical Center TKI258A2211 (SC), Los Angeles

University of California at Los Angeles UCLA 3, Los Angeles

St. Jude Heritage Medical Group St Jude, Fullerton

Cancer Care Northwest SC, Spokane

Rocky Mountain Cancer Centers Dept. of Rocky Mountain Cancer, Greenwood Village

Virginia Oncology Associates VOA - Lake Wright, *see Various Departments*

Novartis Investigative Site, Grafton, Auckland

Dana Farber Cancer Institute SC, Boston

Novartis Investigative Site, Belo Horizonte

Novartis Investigative Site, Porto Alegre

Novartis Investigative Site, Ribeirão Preto

Novartis Investigative Site, Roma

Novartis Investigative Site, Seoul

Novartis Investigative Site, Seoul

Novartis Investigative Site, Sabadell

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Glasgow

Novartis Investigative Site, Leeds

Novartis Investigative Site, London

Novartis Investigative Site, Nottingham